Skip to main content
SpringerLink
Log in

Vigabatrin treatment in children

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Sixty-nine children, aged from 2 months to 16 years and suffering from different types of drugresistant epileptic seizures, mostly complex partial and secondary generalised, were recruited in an open, uncontrolled, prospective study of treatment with vigabatrin (γ-vinyl GABA). Following a 3-month baseline observation of 10 mg/kg per day was progressively increased up to a maximum of 140 mg/kg per day, in addition to the conventional concomitant therapy. Sixteen patients showed a ≥50% reduction in seizure frequency compared with the baseline, with complete control of seizures in nine cases. In 14 other patients, no substantial change in seizure frequency was observed, although an improvement in psychological performance after vigabatrin treatment warranted further continuation of the drug. In 35 patients vigabatrin was discontinued because of lack of efficacy (22 cases) and/or increased seizure frequency (13 cases). The clinical and biological tolerance of vigabatrin was remarkably good.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aicardi J, Arzimanoglou A (1987) Gamma-vinyl GABA (GVG) for child-hood epilepsy: a pilot study. Abstracts, 17th International Epilepsy Congress, Jerusalem, Israel

  2. Ben-Menchem E (1989) Pharmacokinetic effects of vigabatrin on the cerebrospinal amino acids in humans. Epilepsia 30 [Suppl 3]: 125–145

    Google Scholar 

  3. Ben-Menachem E, Persson L, Mumford J (1990) Long-term evaluation of once daily vigabatrin in drug-resistant partial epilepsy. Epilepsy Res 5: 240–256

    Google Scholar 

  4. Browne TR, Mattson RH, Penry JK, et al (1987) Vigabatrin for refractory complex partial seizures. Multicenter single-blind study with long-term follow-up. Neurology 37: 184–189

    Google Scholar 

  5. Chiron C, Mondragon S, Dulac O, et al (1989) Clinical trial of vigabatrin in infantile spasms. Epilepsia 30: 661

    Google Scholar 

  6. Commission of Classification and Terminology minology of the International League Against Epilepsy (1989) Proposal for classification of epilepsy and epileptic syndromes. Epilepsia 30: 389–399

    Google Scholar 

  7. Dam M (1989) Long term evaluation of vigabatrin (gamma-vinyl-GABA) in epilepsy. Epilepsia 30 [Suppl 3]: 26S-30S

    Google Scholar 

  8. Dam M (1991) Vigabatrin in refractory epilepsy in adults and its application in children. J Child Neurol 6 [Suppl 2]: 25S-29S

    Google Scholar 

  9. Dulac O, Chiron C, Luna D, et al (1991) Vigabatrin in childhood epilepsy. J Child Neurol 6 [Suppl 2]: 30S-37S

    Google Scholar 

  10. Grove J, Schechter PJ, Tell G (1981) Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl-GABA (4-amino-hex-5-enoic acid). Life Sci 28: 2431–2439

    Google Scholar 

  11. Herranz JL, Arteaga R, Farr IN, et al (1991) Dose-response study of vigabatrin in children with refractory epilepsy. J Child Neurol 6 [Suppl 2]: 45S-51S

    Google Scholar 

  12. Jung MJ, Lippert B, Metcalf BW, Bohlen P (1977) Gamma-vinyl-GABA (4-amino-hex-5-enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 29: 797–802

    Google Scholar 

  13. Lippert B, Metcalf BW, Jung MJ, Casara P (1977) 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74: 441–445

    Google Scholar 

  14. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J (1989) Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 27 [Suppl 1]: 109S-112S

    Google Scholar 

  15. Loeb C, Iudice A, Perucca E, Gnanasakthy A (1992) Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. Ital J Neurol Sci 13: 741–747

    Google Scholar 

  16. Loiseau P, Hardenberg JP, Pestre M, et al (1986) Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl-GABA) in drug-resistant epilepsy. Epilepsia 27: 115–120

    Google Scholar 

  17. Lund D, Dulac O, Pajot N, Beaumont D (1989) Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 30: 430–437

    Google Scholar 

  18. Matilainen R, Pitkanen A, Ruutiainen T, Mervaala E (1989) Vigabatrin in epilepsy in mentally retarded patients. Br J Clin Pharmacol 6 [Suppl 2]: 30S-37S

    Google Scholar 

  19. Meldrum BS, Horton R (1980) Effects of the bicyclic GABA agonist THIP on myoclonic and seizures responses in mice and baboons with reflex epilepsy. Eur J Pharmacol 61: 231–237

    Google Scholar 

  20. Mumford JP, Dam M (1989) Metaanalysis of European placebo-controlled studies of vigabatrin in drug-resistant epilepsy. Br J Clin Pharmacol 27 [Suppl 1]: 101S-108S

    Google Scholar 

  21. Pedley TA, Horton RW, Meldrum BS (1979) Electroencephalographic and behavioural effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, Papio papio. Epilepsia 20: 409–416

    Google Scholar 

  22. Resor SR Jr, Resor LD (1991) A retrospective study of vigabatrin used as adjunctive therapy in 60 patients with refractory epilepsy. Abstract, Annual Meeting of the America Epilepsy Society, Philadelphia, Pennsylvania

  23. Reynolds EH, Ring H, Farr IN, et al (1991) Open, double-blind and longterm study of vigabatrin in chronic epilepsy. Epilepsia 32: 530–538

    Google Scholar 

  24. Schechter PJ (1989) Clinical pharmacology of vigabatrin. Br J Clin Pharmacol 27 [Suppl 1]: 19S-22S

    Google Scholar 

  25. Schechter PJ, Trainer Y, Jung MJ, Bohlen P (1977) Audiogenic seizure protection by elevated GABA concentration in mice: effects of gamma-acetylenic-GABA and gamma-vinyl-GABA, two irreversible GABA-t inhibitors. Eur J Pharmacol 45: 319–328

    Google Scholar 

  26. Schofield PR, Darlison MG (1987) Sequence and functional expression on the GABA — a receptor shows a ligand-gated receptor superfamily. Nature 328: 221–227

    Google Scholar 

  27. Uldall P, Alving J, Gram L, Beck S (1991) Vigabatrin in pediatric epilepsy — an open study. J Child Neurol 6 [Suppl 2]: 38S-44S

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Pediatrics, University of Siena, Via P.A. Mattioli, 10, I-53100, Siena, Italy

    Alberto Fois, Sabrina Buoni, Rosanna Maria Di Bartolo, Virginia Di Marco & Rosa Mostardini

Authors
  1. Alberto Fois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabrina Buoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosanna Maria Di Bartolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Virginia Di Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosa Mostardini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fois, A., Buoni, S., Di Bartolo, R.M. et al. Vigabatrin treatment in children. Child's Nerv Syst 10, 244–248 (1994). https://doi.org/10.1007/BF00301162

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301162

Key words

Search

Navigation